Synthesis and Antiviral Evaluation of 3'-Fluoro-4'-modified-5'-norcarbocyclic Nucleoside Phosphonates. 2019

Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, Université de Montpellier, CNRS, ENSCM, cc 1705, Site Triolet, Place Eugène Bataillon, 34095, Montpellier cedex 5, France.

The synthesis and anti-HIV evaluation of hitherto unknown 3'-fluoro-5'-norcarbocyclic nucleoside phosphonates bearing adenine with modifications at the 4' position (ethynyl, vinyl, ethyl, hydroxymethyl) is described. One of the synthesized compounds was found to be an inhibitor of HIV-1 replication, but with moderate efficiency relative to (R)-9-(2-phosphonylmethoxypropyl)adenine ((R)-PMPA, tenofovir), with no concomitant cytotoxicity.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D001773 Blood Cells The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM. Blood Corpuscles,Blood Cell,Blood Corpuscle,Cell, Blood,Cells, Blood,Corpuscle, Blood,Corpuscles, Blood
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068698 Tenofovir An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone. (R)-9-(2-phosphonylmethoxypropyl)adenine,9-(2-Phosphonomethoxypropyl)adenine,9-(2-Phosphonylmethoxypropyl)adenine,9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer,9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098,9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer,9-PMPA (tenofovir),Tenofovir Disoproxil,Tenofovir Disoproxil Fumarate,Viread,Disoproxil Fumarate, Tenofovir,Disoproxil, Tenofovir,Fumarate, Tenofovir Disoproxil
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
August 2020, Molecules (Basel, Switzerland),
Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
April 2018, European journal of medicinal chemistry,
Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
July 2017, Organic & biomolecular chemistry,
Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
April 2018, European journal of medicinal chemistry,
Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
January 2004, Nucleosides, nucleotides & nucleic acids,
Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
January 2021, Acta naturae,
Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
January 2008, Nucleic acids symposium series (2004),
Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
March 2006, Tetrahedron,
Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
January 2002, Bioorganicheskaia khimiia,
Pierre-Yves Geant, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
January 2014, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!